1 Min Read
Jan 23 (Reuters) - Cynata Therapeutics Ltd:
* ENTERED INTO A MOU WITH CELULARITY, INC., FOR COMMERCIAL EVALUATION OF CYNATA‘S CYMERUSTM PRODUCTION TECHNOLOGY Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.